We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trade Deal Signing Sets the Stage for New Biologics Exclusivity Policy
Trade Deal Signing Sets the Stage for New Biologics Exclusivity Policy
With 12 nations signing off on the Trans-Pacific Partnership, the clock has started on ratification of the treaty providing up to eight years of exclusivity for biologics.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor